Literature DB >> 3489188

Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor.

R Munker, J Gasson, M Ogawa, H P Koeffler.   

Abstract

Tumor necrosis factor (TNF) is synthesized by macrophages exposed to endotoxin. It produces haemorrhagic necrosis of a variety of tumours in mice and is cytostatic or cytocidal against various transformed cell lines in vitro, but viability of normal human or rodent cells is unaffected. The role of TNF is unlikely to be restricted to the rejection of tumours. Colony-stimulating factors (CSFs) are required for survival, proliferation and differentiation of haematopoietic progenitor cells. The haematopoietic growth factor known as granulocyte-monocyte colony-stimulating factor (GM-CSF) has the ability to stimulate proliferation and differentiation of normal granulocyte-monocyte and eosinophil stem cells and enhance the proliferation of pluripotent, megakaryocyte and erythroid stem cells. In addition, GM-CSF stimulates a variety of functional activities in mature granulocytes and macrophages, for example inhibition of migration, phagocytosis of microbes, oxidative metabolism, and antibody-dependent cytotoxic killing of tumour cells. We show here that TNF markedly stimulates production of GM-CSF messenger RNA and protein in normal human lung fibroblasts and vascular endothelial cells, and in cells of several malignant tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489188     DOI: 10.1038/323079a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  87 in total

1.  TNF-alpha induced altered signaling mechanism in human neutrophil.

Authors:  S Das; S Bhattacharyya; S Ghosh; S Majumdar
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  Critical role of the C-terminus in the biological activities of human tumour necrosis factor-alpha.

Authors:  K Gase; V G Korobko; H G Wisniewski; J Le; V N Dobrynin; S A Filippov; W Gutsche; Y N Maksimova; B Schlott; L N Shingarova
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

Review 3.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

4.  Tumor necrosis factor expression in human epithelial tumor cell lines.

Authors:  D R Spriggs; K Imamura; C Rodriguez; E Sariban; D W Kufe
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  Tumor necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells.

Authors:  M W Marino; L M Pfeffer; P T Guidon; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 6.  Use of immune modulators in nonspecific therapy of bacterial infections.

Authors:  M T Vogels; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

7.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

Authors:  G C Bagby; C A Dinarello; R C Neerhout; D Ridgway; E McCall
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Tumour necrosis factor in synovial exudates.

Authors:  F S Di Giovine; G Nuki; G W Duff
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

9.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.

Authors:  I Doelker; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.